A mutual exclusivity between TP53 and CDKN2A alterations has been previously described in large B-cell lymphomas and BL48, however, using our approach and considering p-value <0.1 as cut-off for mutual exclusivity, we did not identify this association in our series. The gene discussed is TP53; the disease is B-cell non-Hodgkin lymphoma.